25 XP   0   0   10

Chimerix Inc
Buy, Hold or Sell?

Let's analyse Chimerix together

PenkeI guess you are interested in Chimerix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chimerix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Chimerix Inc

I send you an email if I find something interesting about Chimerix Inc.

Quick analysis of Chimerix (30 sec.)










What can you expect buying and holding a share of Chimerix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.16
Expected worth in 1 year
$1.45
How sure are you?
12.5%

+ What do you gain per year?

Total Gains per Share
$-0.72
Return On Investment
-79.0%

For what price can you sell your share?

Current Price per Share
$0.91
Expected price per share
$0.88 - $1.1
How sure are you?
50%

1. Valuation of Chimerix (5 min.)




Live pricePrice per Share (EOD)

$0.91

Intrinsic Value Per Share

$-8.94 - $-7.70

Total Value Per Share

$-6.78 - $-5.54

2. Growth of Chimerix (5 min.)




Is Chimerix growing?

Current yearPrevious yearGrowGrow %
How rich?$193m$151.6m$64.8m29.9%

How much money is Chimerix making?

Current yearPrevious yearGrowGrow %
Making money-$19.8m$43m-$62.8m-317.2%
Net Profit Margin-187,518.0%-43,064.7%--

How much money comes from the company's main activities?

3. Financial Health of Chimerix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#261 / 1010

Most Revenue
#639 / 1010

Most Profit
#694 / 1010

Most Efficient
#1002 / 1010

What can you expect buying and holding a share of Chimerix? (5 min.)

Welcome investor! Chimerix's management wants to use your money to grow the business. In return you get a share of Chimerix.

What can you expect buying and holding a share of Chimerix?

First you should know what it really means to hold a share of Chimerix. And how you can make/lose money.

Speculation

The Price per Share of Chimerix is $0.906. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chimerix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chimerix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.16. Based on the TTM, the Book Value Change Per Share is $-0.18 per quarter. Based on the YOY, the Book Value Change Per Share is $0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chimerix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-22.5%-0.23-25.4%0.4853.3%-0.13-14.8%-0.18-19.5%
Usd Book Value Change Per Share-0.17-18.9%-0.18-19.7%0.5358.3%0.011.0%0.032.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.17-18.9%-0.18-19.7%0.5358.3%0.011.0%0.032.9%
Usd Price Per Share0.96-1.10-2.61-3.39-9.22-
Price to Earnings Ratio-1.18--1.21--1.98--4.09--10.92-
Price-to-Total Gains Ratio-5.62--6.12--9.58--20.15--38.93-
Price to Book Ratio0.44-0.45-4.12-3.22-4.52-
Price-to-Total Gains Ratio-5.62--6.12--9.58--20.15--38.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.906
Number of shares1103
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.180.01
Usd Total Gains Per Share-0.180.01
Gains per Quarter (1103 shares)-197.299.54
Gains per Year (1103 shares)-789.1738.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-789-79903828
20-1578-158807666
30-2368-23770114104
40-3157-31660153142
50-3946-39550191180
60-4735-47440229218
70-5524-55330267256
80-6313-63220305294
90-7103-71110343332
100-7892-79000381370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%2.046.01.04.1%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%5.035.00.012.5%8.038.03.016.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.049.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%5.035.00.012.5%8.038.03.016.3%

Fundamentals of Chimerix

About Chimerix Inc

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase 3 clinical trial for treating patients with H3 K27M-mutant diffuse glioma, as well as in Phase 2 clinical trial for the treatment of rare neuroendocrine tumors; and ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist, which is in Phase 1 clinical trial for adult and pediatric patients with primary central nervous system tumors. The company also develops ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for oncology indications; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of SARS-CoV-2. It has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Fundamental data was last updated by Penke on 2024-04-11 04:33:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Chimerix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chimerix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Chimerix to the Biotechnology industry mean.
  • A Net Profit Margin of -454,025.0% means that $-4,540.25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chimerix Inc:

  • The MRQ is -454,025.0%. The company is making a huge loss. -2
  • The TTM is -187,518.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-454,025.0%TTM-187,518.0%-266,507.0%
TTM-187,518.0%YOY-43,064.7%-144,453.3%
TTM-187,518.0%5Y-52,298.7%-135,219.3%
5Y-52,298.7%10Y-26,978.0%-25,320.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-454,025.0%-200.1%-453,824.9%
TTM-187,518.0%-216.8%-187,301.2%
YOY-43,064.7%-288.3%-42,776.4%
5Y-52,298.7%-449.1%-51,849.6%
10Y-26,978.0%-605.5%-26,372.5%
1.1.2. Return on Assets

Shows how efficient Chimerix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chimerix to the Biotechnology industry mean.
  • -8.5% Return on Assets means that Chimerix generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chimerix Inc:

  • The MRQ is -8.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.5%TTM-8.5%0.0%
TTM-8.5%YOY-1.8%-6.8%
TTM-8.5%5Y-14.7%+6.2%
5Y-14.7%10Y-11.2%-3.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.5%-13.3%+4.8%
TTM-8.5%-12.8%+4.3%
YOY-1.8%-11.7%+9.9%
5Y-14.7%-13.9%-0.8%
10Y-11.2%-15.7%+4.5%
1.1.3. Return on Equity

Shows how efficient Chimerix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chimerix to the Biotechnology industry mean.
  • -9.4% Return on Equity means Chimerix generated $-0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chimerix Inc:

  • The MRQ is -9.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-9.2%-0.2%
TTM-9.2%YOY-14.0%+4.8%
TTM-9.2%5Y-19.9%+10.7%
5Y-19.9%10Y-14.0%-5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.4%-16.9%+7.5%
TTM-9.2%-16.1%+6.9%
YOY-14.0%-15.1%+1.1%
5Y-19.9%-19.3%-0.6%
10Y-14.0%-20.2%+6.2%

1.2. Operating Efficiency of Chimerix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chimerix is operating .

  • Measures how much profit Chimerix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chimerix to the Biotechnology industry mean.
  • An Operating Margin of -520,850.0% means the company generated $-5,208.50  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chimerix Inc:

  • The MRQ is -520,850.0%. The company is operating very inefficient. -2
  • The TTM is -213,537.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-520,850.0%TTM-213,537.6%-307,312.4%
TTM-213,537.6%YOY-43,340.4%-170,197.2%
TTM-213,537.6%5Y-56,669.6%-156,868.0%
5Y-56,669.6%10Y-29,176.2%-27,493.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-520,850.0%-296.2%-520,553.8%
TTM-213,537.6%-232.5%-213,305.1%
YOY-43,340.4%-298.2%-43,042.2%
5Y-56,669.6%-492.1%-56,177.5%
10Y-29,176.2%-632.4%-28,543.8%
1.2.2. Operating Ratio

Measures how efficient Chimerix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5,203.50 means that the operating costs are $5,203.50 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Chimerix Inc:

  • The MRQ is 5,203.500. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2,297.358. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5,203.500TTM2,297.358+2,906.142
TTM2,297.358YOY434.402+1,862.956
TTM2,297.3585Y605.270+1,692.088
5Y605.27010Y319.628+285.642
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5,203.5003.231+5,200.269
TTM2,297.3583.310+2,294.048
YOY434.4023.890+430.512
5Y605.2705.739+599.531
10Y319.6287.876+311.752

1.3. Liquidity of Chimerix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chimerix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.25 means the company has $10.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Chimerix Inc:

  • The MRQ is 10.248. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.662. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.248TTM12.662-2.414
TTM12.662YOY8.477+4.186
TTM12.6625Y10.233+2.430
5Y10.23310Y13.621-3.389
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.2483.890+6.358
TTM12.6624.173+8.489
YOY8.4775.344+3.133
5Y10.2336.126+4.107
10Y13.6216.448+7.173
1.3.2. Quick Ratio

Measures if Chimerix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chimerix to the Biotechnology industry mean.
  • A Quick Ratio of 18.39 means the company can pay off $18.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chimerix Inc:

  • The MRQ is 18.389. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 23.321. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ18.389TTM23.321-4.932
TTM23.321YOY11.037+12.284
TTM23.3215Y16.857+6.463
5Y16.85710Y23.176-6.318
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.3893.514+14.875
TTM23.3213.998+19.323
YOY11.0375.380+5.657
5Y16.8576.105+10.752
10Y23.1766.404+16.772

1.4. Solvency of Chimerix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chimerix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chimerix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Chimerix assets are financed with 9.3% credit (debt) and the remaining percentage (100% - 9.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chimerix Inc:

  • The MRQ is 0.093. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.077. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.093TTM0.077+0.016
TTM0.077YOY0.224-0.147
TTM0.0775Y0.142-0.065
5Y0.14210Y0.098+0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0930.339-0.246
TTM0.0770.336-0.259
YOY0.2240.271-0.047
5Y0.1420.366-0.224
10Y0.0980.389-0.291
1.4.2. Debt to Equity Ratio

Measures if Chimerix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chimerix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.2% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chimerix Inc:

  • The MRQ is 0.102. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.084. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.102TTM0.084+0.018
TTM0.084YOY0.362-0.278
TTM0.0845Y0.190-0.106
5Y0.19010Y0.123+0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1020.388-0.286
TTM0.0840.402-0.318
YOY0.3620.335+0.027
5Y0.1900.426-0.236
10Y0.1230.461-0.338

2. Market Valuation of Chimerix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Chimerix generates.

  • Above 15 is considered overpriced but always compare Chimerix to the Biotechnology industry mean.
  • A PE ratio of -1.18 means the investor is paying $-1.18 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chimerix Inc:

  • The EOD is -1.113. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.182. Based on the earnings, the company is expensive. -2
  • The TTM is -1.211. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.113MRQ-1.182+0.069
MRQ-1.182TTM-1.211+0.029
TTM-1.211YOY-1.975+0.765
TTM-1.2115Y-4.094+2.884
5Y-4.09410Y-10.925+6.831
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.113-2.264+1.151
MRQ-1.182-2.629+1.447
TTM-1.211-2.680+1.469
YOY-1.975-4.145+2.170
5Y-4.094-6.257+2.163
10Y-10.925-6.254-4.671
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chimerix Inc:

  • The EOD is -1.391. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.478. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.453. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.391MRQ-1.478+0.087
MRQ-1.478TTM-1.453-0.025
TTM-1.453YOY-1.181-0.272
TTM-1.4535Y-4.891+3.438
5Y-4.89110Y-13.260+8.369
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.391-2.973+1.582
MRQ-1.478-3.333+1.855
TTM-1.453-3.553+2.100
YOY-1.181-5.605+4.424
5Y-4.891-8.376+3.485
10Y-13.260-8.865-4.395
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chimerix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.44 means the investor is paying $0.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Chimerix Inc:

  • The EOD is 0.419. Based on the equity, the company is cheap. +2
  • The MRQ is 0.445. Based on the equity, the company is cheap. +2
  • The TTM is 0.451. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.419MRQ0.445-0.026
MRQ0.445TTM0.451-0.006
TTM0.451YOY4.117-3.665
TTM0.4515Y3.220-2.769
5Y3.22010Y4.519-1.299
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.4191.896-1.477
MRQ0.4452.115-1.670
TTM0.4512.093-1.642
YOY4.1172.884+1.233
5Y3.2203.542-0.322
10Y4.5193.916+0.603
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Chimerix Inc.

3.1. Institutions holding Chimerix Inc

Institutions are holding 50.033% of the shares of Chimerix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC9.86430.13238800000229837635.3508
2023-12-31Monaco Asset Management4.90711.2401437767400
2023-12-31Vanguard Group Inc4.87120.0001434557900
2023-12-31Armistice Capital, LLC2.91220.03412598000-274000-9.5404
2023-09-30Citadel Advisors Llc2.720.00052426526-350269-12.6141
2023-12-31Goldman Sachs Group Inc2.64440.000223590661193922102.4699
2023-12-31Acadian Asset Management LLC2.11060.0071882832-159051-7.7894
2023-12-31Renaissance Technologies Corp1.75090.0023156200952090050.0332
2023-12-31Vestal Point Capital LP1.56930.1428140000014000000
2023-12-31Millennium Management LLC1.21910.00051087603-721878-39.8942
2023-12-31BlackRock Inc1.172901046352-4134-0.3935
2023-12-31Bridgeway Capital Management, LLC1.15630.02131031524800008.4076
2023-12-31Geode Capital Management, LLC1.02320.0001912760-2657-0.2903
2023-12-31Barclays PLC0.99960.0003891710571666.85
2023-12-31Northern Trust Corp0.77380.0001690317-38026-5.2209
2023-12-31Tejara Capital Ltd0.61660.221855007617743647.6159
2023-12-31Yakira Capital Management, Inc.0.56990.159450838900
2023-12-31Assenagon Asset Management SA0.55980.00134993917271917.0433
2023-12-31Bank of New York Mellon Corp0.4770.0001425503-166194-28.0877
2023-12-31Adage Capital Partners Gp LLC0.44840.000840000000
Total 42.36661.965137795311+4084310+10.8%

3.2. Funds holding Chimerix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.25560.0002290436000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.46720.0015130890600
2023-12-31Bridgeway Ultra-Small Company0.90860.98105248000010.951
2023-12-31Northern Small Cap Value0.53850.0284480410-37442-7.2303
2024-02-29Fidelity Extended Market Index0.48340.0013431245-2089-0.4821
2024-03-31A4Investments SICAV SIF ACCI IlanaA2EURH0.33632.92543000005000020
2023-12-31Bridgeway Ultra-Small Company Market0.24770.114522100000
2023-09-30BlackRock Extended Mkt Composite0.24720.001522056400
2024-02-29SQUAD Point Five I0.22450.145420026500
2024-03-31BlackRock Extended Equity Market K0.21580.0014192493690.0359
2024-03-28iShares Micro-Cap ETF0.20630.021218403100
2024-02-29Fidelity Total Market Index0.17550.000215653800
2024-02-29Fidelity Series Total Market Index0.1240.000211066400
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0810.00117229000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.07980.00127120600
2023-12-31Northern Trust Extended Eq Market Idx0.07980.00127120600
2023-12-31RBC Microcap Value I0.07440.056166400-17000-20.3837
2024-02-29Fidelity Nasdaq Composite Index0.07310.00056522600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06510.0011580591090.1881
2024-02-29Vanguard Balanced Index Inv0.0640.00015713500
Total 8.94784.20257982522+73647+0.9%

3.3. Insider Transactions

Insiders are holding 6.446% of the shares of Chimerix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-14David JakemanSELL26601.04
2024-02-14Michael T AndrioleSELL17441.04
2024-02-14Michelle LaspalutoSELL19401.04
2023-11-10Fred A MiddletonBUY27050.92
2023-09-28David JakemanSELL36100.99
2023-09-25Fred A MiddletonBUY200000.98
2023-05-18Michael T AndrioleBUY517001.14
2023-05-10Martha J DemskiBUY180001.11
2023-05-08Robert J MeyerBUY87501.14

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Chimerix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.171-0.179+4%0.529-132%0.009-2080%0.026-747%
Book Value Per Share--2.1642.426-11%1.700+27%1.560+39%2.183-1%
Current Ratio--10.24812.662-19%8.477+21%10.233+0%13.621-25%
Debt To Asset Ratio--0.0930.077+20%0.224-59%0.142-35%0.098-5%
Debt To Equity Ratio--0.1020.084+22%0.362-72%0.190-46%0.123-17%
Dividend Per Share----0%-0%-0%-0%
Eps---0.204-0.230+13%0.482-142%-0.134-34%-0.177-13%
Free Cash Flow Per Share---0.163-0.194+19%-0.132-19%-0.184+13%-0.181+11%
Free Cash Flow To Equity Per Share---0.162-0.193+19%-0.167+3%-0.127-22%-0.041-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---7.700--------
Intrinsic Value_10Y_min---8.940--------
Intrinsic Value_1Y_max---0.733--------
Intrinsic Value_1Y_min---0.828--------
Intrinsic Value_3Y_max---2.231--------
Intrinsic Value_3Y_min---2.561--------
Intrinsic Value_5Y_max---3.765--------
Intrinsic Value_5Y_min---4.362--------
Market Cap80824622.400-6%85865010.00097959709.980-12%233062170.000-63%302255094.396-72%822458109.798-90%
Net Profit Margin---4540.250-1875.180-59%-430.647-91%-522.987-88%-269.780-94%
Operating Margin---5208.500-2135.376-59%-433.404-92%-566.696-89%-291.762-94%
Operating Ratio--5203.5002297.358+126%434.402+1098%605.270+760%319.628+1528%
Pb Ratio0.419-6%0.4450.451-1%4.117-89%3.220-86%4.519-90%
Pe Ratio-1.113+6%-1.182-1.211+2%-1.975+67%-4.094+246%-10.925+824%
Price Per Share0.906-6%0.9631.098-12%2.613-63%3.388-72%9.219-90%
Price To Free Cash Flow Ratio-1.391+6%-1.478-1.453-2%-1.181-20%-4.891+231%-13.260+797%
Price To Total Gains Ratio-5.292+6%-5.622-6.124+9%-9.580+70%-20.150+258%-38.931+593%
Quick Ratio--18.38923.321-21%11.037+67%16.857+9%23.176-21%
Return On Assets---0.085-0.0850%-0.018-79%-0.147+73%-0.112+31%
Return On Equity---0.094-0.092-2%-0.140+49%-0.199+112%-0.140+49%
Total Gains Per Share---0.171-0.179+4%0.529-132%0.009-2080%0.026-747%
Usd Book Value--193029000.000216438750.000-11%151633750.000+27%139198600.000+39%194771175.000-1%
Usd Book Value Change Per Share---0.171-0.179+4%0.529-132%0.009-2080%0.026-747%
Usd Book Value Per Share--2.1642.426-11%1.700+27%1.560+39%2.183-1%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.204-0.230+13%0.482-142%-0.134-34%-0.177-13%
Usd Free Cash Flow---14526000.000-17278750.000+19%-11734500.000-19%-16381250.000+13%-16166475.000+11%
Usd Free Cash Flow Per Share---0.163-0.194+19%-0.132-19%-0.184+13%-0.181+11%
Usd Free Cash Flow To Equity Per Share---0.162-0.193+19%-0.167+3%-0.127-22%-0.041-75%
Usd Market Cap80824622.400-6%85865010.00097959709.980-12%233062170.000-63%302255094.396-72%822458109.798-90%
Usd Price Per Share0.906-6%0.9631.098-12%2.613-63%3.388-72%9.219-90%
Usd Profit---18161000.000-19812250.000+9%43037500.000-142%-11821650.000-35%-15749125.000-13%
Usd Revenue--4000.00081000.000-95%8456000.000-100%2700900.000-100%2155800.000-100%
Usd Total Gains Per Share---0.171-0.179+4%0.529-132%0.009-2080%0.026-747%
 EOD+3 -5MRQTTM+16 -17YOY+14 -195Y+15 -1810Y+10 -23

4.2. Fundamental Score

Let's check the fundamental score of Chimerix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.113
Price to Book Ratio (EOD)Between0-10.419
Net Profit Margin (MRQ)Greater than0-4,540.250
Operating Margin (MRQ)Greater than0-5,208.500
Quick Ratio (MRQ)Greater than118.389
Current Ratio (MRQ)Greater than110.248
Debt to Asset Ratio (MRQ)Less than10.093
Debt to Equity Ratio (MRQ)Less than10.102
Return on Equity (MRQ)Greater than0.15-0.094
Return on Assets (MRQ)Greater than0.05-0.085
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Chimerix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.930
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -337106-231-582-813188-6256327



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets212,774
Total Liabilities19,745
Total Stockholder Equity193,029
 As reported
Total Liabilities 19,745
Total Stockholder Equity+ 193,029
Total Assets = 212,774

Assets

Total Assets212,774
Total Current Assets189,010
Long-term Assets23,764
Total Current Assets
Cash And Cash Equivalents 27,661
Short-term Investments 155,174
Net Receivables 1,140
Other Current Assets 5,035
Total Current Assets  (as reported)189,010
Total Current Assets  (calculated)189,010
+/-0
Long-term Assets
Property Plant Equipment 1,706
Long Term Investments 21,657
Long-term Assets Other 401
Long-term Assets  (as reported)23,764
Long-term Assets  (calculated)23,764
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,443
Long-term Liabilities1,302
Total Stockholder Equity193,029
Total Current Liabilities
Short-term Debt 842
Accounts payable 2,851
Other Current Liabilities 14,750
Total Current Liabilities  (as reported)18,443
Total Current Liabilities  (calculated)18,443
+/-0
Long-term Liabilities
Long term Debt 125
Capital Lease Obligations 1,177
Long-term Liabilities  (as reported)1,302
Long-term Liabilities  (calculated)1,302
+/- 0
Total Stockholder Equity
Common Stock89
Retained Earnings -795,524
Accumulated Other Comprehensive Income 7
Other Stockholders Equity 988,457
Total Stockholder Equity (as reported)193,029
Total Stockholder Equity (calculated)193,029
+/-0
Other
Capital Stock89
Cash and Short Term Investments 182,835
Common Stock Shares Outstanding 88,910
Liabilities and Stockholders Equity 212,774
Net Debt -25,517
Net Invested Capital 193,154
Net Working Capital 170,667
Property Plant and Equipment Gross 6,860
Short Long Term Debt Total 2,144



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
> Total Assets 
25,432
0
0
0
32,031
26,333
126,554
120,158
113,387
102,153
204,658
194,009
291,878
274,125
421,508
391,508
355,992
324,238
310,804
297,253
286,770
272,407
257,676
246,085
235,230
214,898
200,980
198,696
190,714
177,988
163,441
127,751
119,376
107,769
101,673
93,504
84,723
158,649
146,725
133,401
100,540
65,516
53,563
293,880
279,341
258,533
241,085
225,282
212,774
212,774225,282241,085258,533279,341293,88053,56365,516100,540133,401146,725158,64984,72393,504101,673107,769119,376127,751163,441177,988190,714198,696200,980214,898235,230246,085257,676272,407286,770297,253310,804324,238355,992391,508421,508274,125291,878194,009204,658102,153113,387120,158126,55426,33332,03100025,432
   > Total Current Assets 
0
0
0
0
31,554
25,880
126,170
119,788
113,009
101,721
204,151
192,879
237,457
177,260
269,293
229,508
228,837
268,805
277,889
254,370
236,465
164,897
151,676
152,590
156,533
163,924
178,311
186,718
189,458
175,545
161,373
125,969
118,093
106,740
98,895
90,243
81,658
148,137
136,250
128,533
95,805
62,550
50,770
291,120
228,138
224,750
211,517
200,622
189,010
189,010200,622211,517224,750228,138291,12050,77062,55095,805128,533136,250148,13781,65890,24398,895106,740118,093125,969161,373175,545189,458186,718178,311163,924156,533152,590151,676164,897236,465254,370277,889268,805228,837229,508269,293177,260237,457192,879204,151101,721113,009119,788126,17025,88031,5540000
       Cash And Cash Equivalents 
13,607
0
0
0
19,906
12,039
115,438
115,891
109,976
37,421
119,601
74,350
128,462
55,605
127,776
44,720
20,605
27,503
32,060
49,358
51,463
21,866
23,891
18,173
18,548
22,112
27,447
22,991
81,106
19,705
21,644
19,349
16,901
24,553
53,501
38,130
46,989
32,080
25,445
26,174
15,397
31,957
28,086
274,261
25,842
15,951
20,099
14,118
27,661
27,66114,11820,09915,95125,842274,26128,08631,95715,39726,17425,44532,08046,98938,13053,50124,55316,90119,34921,64419,70581,10622,99127,44722,11218,54818,17323,89121,86651,46349,35832,06027,50320,60544,720127,77655,605128,46274,350119,60137,421109,976115,891115,43812,03919,90600013,607
       Short-term Investments 
5,918
0
0
0
9,849
10,877
7,595
1,004
0
62,500
80,996
114,072
106,114
118,898
130,555
176,080
199,729
235,832
240,755
200,315
180,558
139,829
124,637
131,547
132,972
138,335
147,316
160,367
105,424
151,881
136,755
97,366
96,574
78,469
42,449
49,635
31,973
112,898
106,584
96,384
72,970
21,421
14,705
10,369
191,492
198,801
185,657
180,357
155,174
155,174180,357185,657198,801191,49210,36914,70521,42172,97096,384106,584112,89831,97349,63542,44978,46996,57497,366136,755151,881105,424160,367147,316138,335132,972131,547124,637139,829180,558200,315240,755235,832199,729176,080130,555118,898106,114114,07280,99662,50001,0047,59510,8779,8490005,918
       Net Receivables 
0
0
0
0
783
1,228
83
190
248
430
288
902
106
977
2,311
525
2,432
566
313
379
1,599
811
0
270
1,682
426
219
332
330
1,425
774
1,822
1,233
1,079
367
378
340
482
36
53
348
0
0
468
1,040
668
26
11
1,140
1,14011266681,0404680034853364823403783671,0791,2331,8227741,4253303322194261,68227008111,5993793135662,4325252,311977106902288430248190831,2287830000
       Inventory 
0
0
0
0
519
1,551
2,373
2,261
2,453
1,106
20
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,595
2,760
3,406
4,126
0
0
0
0
0
0
0000004,1263,4062,7601,59500000000000000000000000000015201,1062,4532,2612,3731,5515190000
   > Long-term Assets 
0
0
0
0
477
453
384
370
378
432
507
1,130
54,421
96,865
152,215
162,000
127,155
55,433
32,915
42,883
50,305
107,510
106,000
93,495
78,697
50,974
22,669
11,978
1,256
2,443
2,068
1,782
1,283
1,029
2,778
3,261
3,065
10,512
10,475
4,868
4,735
2,966
2,793
2,760
51,203
33,783
29,568
24,660
23,764
23,76424,66029,56833,78351,2032,7602,7932,9664,7354,86810,47510,5123,0653,2612,7781,0291,2831,7822,0682,4431,25611,97822,66950,97478,69793,495106,000107,51050,30542,88332,91555,433127,155162,000152,21596,86554,4211,1305074323783703844534770000
       Property Plant Equipment 
561
0
0
0
407
391
342
335
338
387
469
1,095
1,310
1,329
1,996
2,439
3,045
3,006
3,020
3,048
2,843
2,567
2,306
2,044
1,894
1,688
1,502
1,363
1,210
2,390
2,023
1,746
1,249
1,013
2,752
3,234
3,039
2,935
2,910
2,773
2,657
2,527
2,394
2,330
2,191
2,115
1,984
1,854
1,706
1,7061,8541,9842,1152,1912,3302,3942,5272,6572,7732,9102,9353,0393,2342,7521,0131,2491,7462,0232,3901,2101,3631,5021,6881,8942,0442,3062,5672,8433,0483,0203,0063,0452,4391,9961,3291,3101,095469387338335342391407000561
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
52,973
95,239
150,139
159,486
124,040
52,363
29,802
39,801
47,407
104,884
103,643
91,419
76,731
49,225
21,115
10,564
0
0
0
0
0
0
0
0
0
7,548
7,535
2,035
2,022
0
0
0
48,626
31,322
27,258
22,514
21,657
21,65722,51427,25831,32248,6260002,0222,0357,5357,54800000000010,56421,11549,22576,73191,419103,643104,88447,40739,80129,80252,363124,040159,486150,13995,23952,973000000000000
       Long-term Assets Other 
0
0
0
0
22
22
22
20
30
32
32
30
138
297
80
75
70
64
93
34
55
59
51
32
72
61
52
51
46
53
45
36
34
16
26
27
26
29
30
60
56
439
399
430
386
346
326
292
401
40129232634638643039943956603029262726163436455346515261723251595534936470758029713830323230202222220000
       Deferred Long Term Asset Charges 
0
0
0
0
0
40
20
15
10
13
6
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000056131015204000000
> Total Liabilities 
15,746
0
0
0
17,827
28,476
15,510
15,028
14,848
12,529
13,983
17,396
17,242
16,603
22,195
21,297
20,533
10,537
10,834
9,903
10,546
9,033
8,014
9,186
13,420
9,207
9,587
9,552
13,110
13,681
14,323
15,803
9,424
6,728
8,538
10,335
11,347
25,000
27,576
28,815
32,288
17,718
25,635
19,928
22,484
18,222
16,973
16,979
19,745
19,74516,97916,97318,22222,48419,92825,63517,71832,28828,81527,57625,00011,34710,3358,5386,7289,42415,80314,32313,68113,1109,5529,5879,20713,4209,1868,0149,03310,5469,90310,83410,53720,53321,29722,19516,60317,24217,39613,98312,52914,84815,02815,51028,47617,82700015,746
   > Total Current Liabilities 
6,814
0
0
0
7,623
9,943
8,050
8,968
10,207
9,290
12,218
16,521
17,067
16,442
22,061
21,076
20,179
10,206
10,528
9,618
10,105
8,632
7,768
8,987
13,196
9,001
9,402
9,385
12,966
12,881
13,786
15,434
9,228
6,680
6,236
7,412
8,533
22,248
24,922
26,290
29,896
15,212
23,271
17,710
20,415
16,431
15,341
15,510
18,443
18,44315,51015,34116,43120,41517,71023,27115,21229,89626,29024,92222,2488,5337,4126,2366,6809,22815,43413,78612,88112,9669,3859,4029,00113,1968,9877,7688,63210,1059,61810,52810,20620,17921,07622,06116,44217,06716,52112,2189,29010,2078,9688,0509,9437,6230006,814
       Short-term Debt 
0
0
0
0
4,753
5,519
5,584
5,597
5,573
5,590
5,610
5,329
4,296
2,892
1,484
375
354
0
0
0
441
401
246
199
224
206
185
0
0
640
0
0
0
0
0
0
375
14,000
14,000
14,000
14,000
0
540
557
773
-590
607
824
842
842824607-590773557540014,00014,00014,00014,000375000000640001852062241992464014410003543751,4842,8924,2965,3295,6105,5905,5735,5975,5845,5194,7530000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
4,296
0
0
0
354
0
0
0
441
401
246
199
224
206
185
0
0
640
0
0
0
0
0
0
0
14,000
14,000
14,000
14,000
0
0
0
0
0
0
0
0
0000000014,00014,00014,00014,0000000000640001852062241992464014410003540004,296000000000000
       Accounts payable 
4,120
0
0
0
1,964
2,711
995
1,770
2,214
1,806
3,055
5,846
5,938
6,920
9,819
12,919
10,458
3,568
4,217
3,280
3,890
2,813
1,609
1,571
3,812
1,892
1,426
1,609
4,691
2,492
1,832
3,477
2,398
1,124
1,425
880
1,283
2,181
1,457
1,792
2,788
3,494
1,743
3,282
3,034
2,847
1,823
2,502
2,851
2,8512,5021,8232,8473,0343,2821,7433,4942,7881,7921,4572,1811,2838801,4251,1242,3983,4771,8322,4924,6911,6091,4261,8923,8121,5711,6092,8133,8903,2804,2173,56810,45812,9199,8196,9205,9385,8463,0551,8062,2141,7709952,7111,9640004,120
       Other Current Liabilities 
2,534
0
0
0
906
1,713
1,471
1,601
2,420
1,894
3,553
5,346
5,288
6,630
10,758
7,782
9,721
6,638
6,311
6,338
6,215
5,819
6,159
7,416
9,384
7,109
7,976
7,776
8,275
10,389
11,954
6,876
6,830
5,556
4,811
6,532
7,250
6,067
9,465
10,498
27,108
11,718
16,142
14,428
17,381
13,584
13,518
13,008
14,750
14,75013,00813,51813,58417,38114,42816,14211,71827,10810,4989,4656,0677,2506,5324,8115,5566,8306,87611,95410,3898,2757,7767,9767,1099,3847,4166,1595,8196,2156,3386,3116,6389,7217,78210,7586,6305,2885,3463,5531,8942,4201,6011,4711,7139060002,534
   > Long-term Liabilities 
0
0
0
0
10,204
18,533
7,460
6,060
4,641
3,239
1,765
875
175
161
134
221
354
331
306
285
441
401
246
199
224
206
185
167
144
800
537
369
196
48
2,302
2,923
2,814
2,752
2,654
2,525
2,392
2,506
2,364
2,218
2,069
1,791
1,632
1,469
1,302
1,3021,4691,6321,7912,0692,2182,3642,5062,3922,5252,6542,7522,8142,9232,302481963695378001441671852062241992464014412853063313542211341611758751,7653,2394,6416,0607,46018,53310,2040000
       Long term Debt Total 
0
0
0
0
0
8,480
7,119
5,715
4,294
2,889
1,480
366
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000003661,4802,8894,2945,7157,1198,48000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-4,753
-5,519
-5,584
-5,597
-5,573
-5,590
-5,610
-5,329
-4,296
-2,892
-1,484
-375
-354
0
0
0
-441
-401
-246
-199
-224
-206
-185
0
0
160
537
369
196
48
2,302
2,923
2,439
-11,248
-11,346
-11,475
-11,608
2,256
1,574
1,411
1,046
2,256
900
520
335
3355209002,2561,0461,4111,5742,256-11,608-11,475-11,346-11,2482,4392,9232,3024819636953716000-185-206-224-199-246-401-441000-354-375-1,484-2,892-4,296-5,329-5,610-5,590-5,573-5,597-5,584-5,519-4,7530000
       Deferred Long Term Asset Charges 
0
0
0
0
0
40
20
15
10
13
6
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000056131015204000000
       Long-term Liabilities Other 
0
0
0
0
0
10,053
341
345
347
350
285
509
175
161
134
221
354
0
0
0
0
0
0
0
224
0
0
0
144
800
537
369
196
48
0
0
2,814
0
0
0
2,392
2,506
2,364
2,218
0
1,791
1,632
0
0
001,6321,79102,2182,3642,5062,3920002,8140048196369537800144000224000000035422113416117550928535034734534110,05300000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
331
306
285
441
401
246
199
0
206
185
167
0
0
0
0
0
0
0
0
0
0
0
0
0
400
400
300
300
0
0
0
0
00003003004004000000000000000167185206019924640144128530633100000000000000000
> Total Stockholder Equity
9,686
0
0
0
14,204
-2,143
111,044
105,130
98,539
89,624
190,675
176,613
274,636
257,522
399,313
370,211
335,459
313,701
299,970
287,350
276,224
263,374
249,662
236,899
221,810
205,691
191,393
189,144
177,604
164,307
149,118
111,948
109,952
101,041
93,135
83,169
73,376
133,649
119,149
104,586
68,252
47,798
27,928
273,952
256,857
240,311
224,112
208,303
193,029
193,029208,303224,112240,311256,857273,95227,92847,79868,252104,586119,149133,64973,37683,16993,135101,041109,952111,948149,118164,307177,604189,144191,393205,691221,810236,899249,662263,374276,224287,350299,970313,701335,459370,211399,313257,522274,636176,613190,67589,62498,539105,130111,044-2,14314,2040009,686
   Common Stock
2
0
0
0
17
3
26
26
26
27
35
35
41
41
46
46
46
46
46
46
46
47
47
47
47
48
48
51
51
51
51
61
62
62
62
63
63
86
86
87
87
87
87
88
88
89
89
89
89
898989898888878787878686636362626261515151514848474747474646464646464641413535272626263170002
   Retained Earnings Total Equity00-753,377-734,801-713,429-692,469-933,831-910,363-885,596-846,098-827,538-809,775-712,360-700,685-689,274-679,258-668,838-665,335-591,605-573,955-556,262-541,306-525,227-506,614-486,788-467,550-450,239-433,559-415,804-400,848-383,822-365,674-339,414-301,571-269,122-244,308-222,042-201,795-184,844-173,110-162,730-154,557-147,851-135,39100000
   Accumulated Other Comprehensive Income 
0
0
0
0
-2
-3
-1
-1,431
-1,159
-32
-20
-63
35
659
1,803
356
-764
-343
-269
-366
-440
-109
-1,475
-1,481
-963
-1,066
-842
-661
-92
48
125
89
35
-11
130
33
0
-43
-11
0
-21
-73
-68
-37
-337
-231
-813
-625
7
7-625-813-231-337-37-68-73-210-11-43033130-11358912548-92-661-842-1,066-963-1,481-1,475-109-440-366-269-343-7643561,80365935-63-20-32-1,159-1,431-1-3-20000
   Capital Surplus 
0
0
0
0
0
0
258,870
259,661
261,243
262,739
375,504
378,436
496,602
501,130
666,586
671,380
675,591
679,672
684,015
688,518
692,422
696,995
701,329
705,883
709,514
713,323
717,414
731,060
733,907
738,163
740,547
777,133
778,693
780,248
782,217
783,758
785,673
943,381
946,612
950,597
953,782
958,147
961,740
966,370
970,535
975,254
978,213
0
0
00978,213975,254970,535966,370961,740958,147953,782950,597946,612943,381785,673783,758782,217780,248778,693777,133740,547738,163733,907731,060717,414713,323709,514705,883701,329696,995692,422688,518684,015679,672675,591671,380666,586501,130496,602378,436375,504262,739261,243259,661258,870000000
   Treasury Stock0000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
116,197
-3
132,316
140,934
261,243
262,739
375,504
378,436
496,602
501,130
666,586
671,380
675,591
679,672
684,015
688,518
692,422
696,995
701,329
705,883
709,514
713,323
717,414
731,060
733,907
738,163
740,547
777,133
778,693
780,248
782,217
783,758
785,673
943,381
946,612
950,597
953,782
958,147
961,740
966,370
970,535
975,254
978,213
986,202
988,457
988,457986,202978,213975,254970,535966,370961,740958,147953,782950,597946,612943,381785,673783,758782,217780,248778,693777,133740,547738,163733,907731,060717,414713,323709,514705,883701,329696,995692,422688,518684,015679,672675,591671,380666,586501,130496,602378,436375,504262,739261,243140,934132,316-3116,1970000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue324
Cost of Revenue-1
Gross Profit323323
 
Operating Income (+$)
Gross Profit323
Operating Expense-93,388
Operating Income-93,065-93,065
 
Operating Expense (+$)
Research Development68,788
Selling General Administrative24,601
Selling And Marketing Expenses-1
Operating Expense93,38893,388
 
Net Interest Income (+$)
Interest Income11,058
Interest Expense-0
Other Finance Cost-0
Net Interest Income11,058
 
Pretax Income (+$)
Operating Income-93,065
Net Interest Income11,058
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-82,095-104,035
EBIT - interestExpense = -93,065
-82,095
-82,095
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-93,065-82,095
Earnings Before Interest and Taxes (EBITDA)-93,064
 
After tax Income (+$)
Income Before Tax-82,095
Tax Provision--117
Net Income From Continuing Ops-84,894-81,978
Net Income-82,095
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses93,389
Total Other Income/Expenses Net10,970-11,058
 

Technical Analysis of Chimerix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chimerix. The general trend of Chimerix is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chimerix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chimerix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.91 < 1.09 < 1.1.

The bearish price targets are: 0.883 > 0.88.

Tweet this
Chimerix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chimerix Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chimerix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chimerix Inc.

Chimerix Inc Daily Moving Average Convergence/Divergence (MACD) ChartChimerix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chimerix Inc. The current adx is .

Chimerix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chimerix Inc.

Chimerix Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chimerix Inc.

Chimerix Inc Daily Relative Strength Index (RSI) ChartChimerix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chimerix Inc.

Chimerix Inc Daily Stochastic Oscillator ChartChimerix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chimerix Inc.

Chimerix Inc Daily Commodity Channel Index (CCI) ChartChimerix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chimerix Inc.

Chimerix Inc Daily Chande Momentum Oscillator (CMO) ChartChimerix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chimerix Inc.

Chimerix Inc Daily Williams %R ChartChimerix Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chimerix Inc.

Chimerix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chimerix Inc.

Chimerix Inc Daily Average True Range (ATR) ChartChimerix Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chimerix Inc.

Chimerix Inc Daily On-Balance Volume (OBV) ChartChimerix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chimerix Inc.

Chimerix Inc Daily Money Flow Index (MFI) ChartChimerix Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chimerix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Chimerix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chimerix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.930
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chimerix with someone you think should read this too:
  • Are you bullish or bearish on Chimerix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chimerix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chimerix Inc

I send you an email if I find something interesting about Chimerix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Chimerix Inc.

Receive notifications about Chimerix Inc in your mailbox!